MEN2 was initially separated into three syndromes: MEN2A (95% of MEN2), MEN2B (also called MEN3), and familial medullary thyroid carcinoma (FMTC), due to very specific clinical presentations that depend on the mutations present. The gene discussed is RET; the disease is familial medullary thyroid carcinoma.